Hyderabad-based pharma major Dr Reddy's Laboratories will buy Wockhardt Ltd's branded generics business in India, Nepal, Sri Lanka, Bhutan and Maldives and its manufacturing plant at Baddi in Himachal Pradesh for around...
Indoco in talks to sell part of India operations
Indoco Remedies NSE 0.86 % is in initial discussions with investors such as Zydus Cadila and Lupin, along with private equity funds including TPG Capital Management and Temasek Holdings to sell part of its domestic...
Aurobindo in last lap to buy Mallinckrodt’s US generics business
Aurobindo Pharma is in final negotiations to acquire Mallinckrodt’s specialty generics business in the US—including its portfolio of opioid-based painkillers—for $850-900 million after talks resumed in May, said...
Aurobindo eyes Mallinckrodt Opioids Again
Even as the Donald Trump administration intensifies its crackdown on the opioid crisis in the US, homegrown Aurobindo PharmaNSE -0.50 % has re-engaged with Mallinckrodt to acquire its specialty generics portfolio. But...
Hyderabad’s Aurobindo in race to buy Novartis’ generic dermatology business
After Ahmedabad’s Torrent Pharmaceuticals dropped the idea to acquire Sanofi’s European generic business last month, Hyderabad-headquartered Aurobindo Pharma is in the race to buy the dermatology generics...
Aurobindo launches $1.6 billion bid to buy Novartis generics unit
Aurobindo Pharma Ltd has submitted an initial bid to buy Novartis AG’s dermatology generics drug business for about $1.6 billion, two people directly aware of the development said on condition of anonymity. Hyderabad...
Torrent Pharma may raise Rs1,500 crore in bid for Sanofi generics business
Torrent Pharma Ltd is likely to raise at least Rs1,500 crore by selling shares to institutional investors, as it prepares a bid for the generic drugs unit of France’s Sanofi, two people aware of the development said...
Torrent Pharma readies €2 billion binding offer for Sanofi’s European unit
Torrent Pharmaceuticals Ltd is readying a €2 billion (Rs16,000 crore) bid for Zentiva N.V., the generic drugs unit of France’s Sanofi, two people directly aware of the bidding process said. If Ahmedabad-based Torrent is...
Aurobindo, Dr Reddy’s Laboratories frontrunners to buy out bankrupt Orchid Pharma
Indian drug companies AurobindoBSE 0.12 % Pharma Ltd. and Dr Reddy’s Laboratories Ltd. are emerging as the frontrunners to buy out bankrupt Orchid Pharma Ltd. as they seek to expand their capacities. A key player...
Intas closing in on Mallinckrodt’s US generics business
Intas Pharmaceuticals, backed by Temasek and ChrysCapital, has inched closer to arguably the biggest cross-border buyout by an Indian pharma company, emerging as the front-runner to acquire Mallinckrodt’s generics drug...
PE funds, domestic pharma companies eye Orchid Pharma under IBC
Two months after a National Company Law Tribunal (NCLT) issued an order initiating corporate insolvency proceedings against debt-ridden Orchid Pharma, numerous potential suitors, including top private equity players and...
M&A deals in pharma sector decline in 2017 amid tough business conditions
Pharmaceutical companies have become cautious with regard to mergers and acquisitions (M&As) as the business environment remains challenging due to pricing pressure and regulatory interventions in key markets—the US...